A Phase I Study of INT-210 Capsules in Healthy Adult Subjects (INT-210-I101)

Clinical trial NCT07616791 · COMPLETED

Trial details

NCT number: NCT07616791
Sponsor: Innatus Therapeutics (Shanghai) Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

IBD (Inflammatory Bowel Disease)

Start date: 2025-09-04
Primary completion: 2026-01-06
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.